Impact of Preterm Single Donor Milk in Very Low Birth Weight Infants

NCT ID: NCT02216292

Last Updated: 2014-08-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-06-30

Study Completion Date

2014-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Human milk is the best source of enteral nutrition for the preterm infant. However during the infants first hours and days of life breastmilk from the own mother is usually not available. Until May 2012 the practice in the Neonatal Division of the Department of Pediatrics /Medical University Vienna was to start with formula feedings within the first 6 hours of life of a premature infant and switch over to breastmilk as soon it was available. In June 2012 the investigators changed this feeding regimen and started to use single donor milk of mothers of preterm infants for the first hours and days of the preterm infants life. In a prospective observational study the investigators evaluated the impact of single donor milk from preterm infants on time to full enteral feedings, gastrointestinal tolerance and NEC incidence in preterm infants with a birthweight below 1500 grams and a gestational below 32 weeks. Data will be compared with a historical control group starting with preterm formula as source of enteral nutrition. The investigators hypothesize that starting enteral nutrition with single donor milk of mothers from preterm infants with shorten time to full enteral feedings.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infant, Premature, Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Preterm Single Donor Milk Group

The prospective study group = preterm single donor milk group (PSDM-Group) from June 2012 - April 2013

Preterm Single Donor Milk Group

Intervention Type OTHER

Infants received preterm single donor milk during their first days of life until breastmilk from their own mother was available

Control Group

Retrospective control group receiving no donor milk = control group from March 2011 - May 2012

Control Group

Intervention Type OTHER

Infants received preterm formula during their first days of life until breastmilk from their own mother was available

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Control Group

Infants received preterm formula during their first days of life until breastmilk from their own mother was available

Intervention Type OTHER

Preterm Single Donor Milk Group

Infants received preterm single donor milk during their first days of life until breastmilk from their own mother was available

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* very low birth weight infants with a birthweight \<1500g
* Gestational Age \<32 weeks
* Informed consent

Exclusion Criteria

* major congenital malformations
* systemic metabolic diseases
* short bowl syndrome
* gastrointestinal abnormalities
* when preterm infant was transferred or discharged
Minimum Eligible Age

1 Minute

Maximum Eligible Age

1 Year

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical University of Vienna

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nadja Haiden,MD

MD, Assoc. Prof.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nadja Haiden, Prof.MD

Role: PRINCIPAL_INVESTIGATOR

Medical University of Vienna, Department of Pediatrics

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical University of Vienna

Vienna, , Austria

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PSDM001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Exclusive Enteral Nutrition in Preterm Neonates
NCT04337710 ACTIVE_NOT_RECRUITING NA
Protein for Premies
NCT01773902 COMPLETED NA
OptiMoM Kindergarten Study
NCT02759809 COMPLETED